Company Filing History:
Years Active: 2019
Title: Yuki Hanya: Innovator in Pharmaceutical Chemistry
Introduction
Yuki Hanya is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target neurological disorders. Her innovative work has the potential to impact the treatment of various mental health conditions.
Latest Patents
Yuki Hanya holds a patent for a heterocyclic compound that exhibits antagonistic action on the NMDA receptor containing the NR2B subunit. This compound is useful as a prophylactic or therapeutic agent for major depression, bipolar disorder, migraine, pain, and peripheral symptoms of dementia. The compound is represented by a specific formula, which is detailed in the patent description.
Career Highlights
Yuki Hanya is currently employed at Takeda Pharmaceutical Company Limited, where she continues to advance her research in pharmaceutical innovations. Her work is characterized by a commitment to developing effective treatments for complex health issues.
Collaborations
Yuki collaborates with esteemed colleagues, including Eiji Kimura and Yuhei Miyanohana, who contribute to her research efforts and enhance the collaborative environment at Takeda Pharmaceutical Company Limited.
Conclusion
Yuki Hanya's contributions to pharmaceutical chemistry exemplify the impact of innovative research on healthcare. Her patent for a heterocyclic compound showcases her dedication to addressing significant medical challenges.